Advertisement
Advertisement
U.S. markets open in 7 hours 19 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Cantabio Pharmaceuticals, Inc. (CTBO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.01000.0000 (0.00%)
At close: 02:08PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.0100
Open1.0100
BidN/A x N/A
AskN/A x N/A
Day's Range1.0100 - 1.0100
52 Week Range1.0100 - 25.0000
Volume24
Avg. Volume0
Market Cap563,600
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-130.8330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CTBO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANTABIO PHARMACEUTICALS INC
    Daily Spotlight: Stock Valuations Still on the High SideOur bond/stock asset-allocation model indicates that both stocks and bonds are over-valued, despite sell-offs in both asset classes in 2022. Our model takes into account current levels and forecasts of short-term and long-term government and corporate fixed-income yields, inflation, stock prices, GDP, and corporate earnings, among other factors. The output is expressed in terms of standard deviations to the mean, or sigma. The mean reading from the model, going back to 1960, is a modest premium for stocks of 0.15 sigma, with a standard deviation of 1.0. The current valuation level is a 1.0 sigma premium for stocks, which is still within the normal range. The model has done a good job of highlighting asset class value. For example, stocks were very attractive compared to bonds in the late 1970s, when benchmark Treasury rates were in the high teens before heading consistently lower, in part due to the benefits of globalization. The model indicated that stocks were at a sharp premium to fair value compared to bonds prior to the "dot-com" crash of 2001 and also at a premium prior to the Great Recession in 2007-2009. In 2009, at the depths of the financial crisis, the model favored stocks over bonds -- another good call. Markets can manage with premiums and discounts for extended periods. Our current asset-allocation model for moderate accounts is 70% growth assets, including 65% equities and 5% alternatives; and 30% fixed income, with 200 basis points of the bond allocation in cash.
    Rating
    Fair Value
    Economic Moat
    23 hours agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement